StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Investment analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Calithera Biosciences has a 1-year low of $0.00 and a 1-year high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.